{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:07:11Z","timestamp":1790755631779,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Japanese Ministry of Health, Labor and Welfare"},{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Japan Foundation for Neuroscience and Mental Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.neulet.2013.09.059","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T05:38:45Z","timestamp":1382074725000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine"],"prefix":"10.1016","volume":"556","author":[{"given":"Hidenaga","family":"Yamamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Umeda-Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2013.09.059_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2010.04.049","article-title":"Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia","volume":"187","author":"Chang","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2013.09.059_bib0010","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"Domenici","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2013.09.059_bib0015","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1126\/science.7907431","article-title":"Requirement for BDNF in activity-dependent survival of cortical neurons","volume":"263","author":"Ghosh","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neulet.2013.09.059_bib0020","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1523\/JNEUROSCI.23-17-06856.2003","article-title":"Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites","volume":"23","author":"Gorski","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0025","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.09.059_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2013.09.059_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1819.2010.02113.x","article-title":"Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions","volume":"64","author":"Hashimoto","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.09.001","article-title":"Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression","volume":"100","author":"Hashimoto","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2013.09.059_bib0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neures.2008.04.003","article-title":"Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity","volume":"61","author":"Hashimoto","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2013.09.059_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000205518","article-title":"Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment","volume":"59","author":"Lee","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neulet.2013.09.059_bib0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety","volume":"10","author":"Martinowich","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0060","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1523\/JNEUROSCI.4359-05.2006","article-title":"Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory","volume":"26","author":"Nagy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.mp.4000730","article-title":"Cytokine and growth factor involvement in schizophrenia \u2013 support for the developmental model","volume":"5","author":"Nawa","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.09.059_bib0070","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/STROKEAHA.109.554824","article-title":"Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats","volume":"40","author":"Park","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neulet.2013.09.059_bib0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2011.01.039","article-title":"Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation","volume":"491","author":"Pedrini","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2013.09.059_bib0080","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1523\/JNEUROSCI.2680-04.2004","article-title":"The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology","volume":"24","author":"Pezawas","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/35049004","article-title":"Neurotrophins as synaptic modulators","volume":"2","author":"Poo","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2013.09.059_bib0090","doi-asserted-by":"crossref","first-page":"904836","DOI":"10.1155\/2009\/904836","article-title":"Matrix metalloproteinase-9 (MMP9) \u2013 a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders","volume":"2009","author":"Rybakowski","year":"2009","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.neulet.2013.09.059_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.09.059_bib0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"Shimizu","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2013.09.059_bib0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.mp.4001308","article-title":"Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia","volume":"8","author":"Weickert","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.09.059_bib0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuroscience.2010.05.037","article-title":"Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia","volume":"169","author":"Wong","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2013.09.059_bib0115","doi-asserted-by":"crossref","first-page":"e42676","DOI":"10.1371\/journal.pone.0042676","article-title":"Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder","volume":"7","author":"Yoshida","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013008835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013008835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:17:05Z","timestamp":1759609025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013008835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":23,"alternative-id":["S0304394013008835"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.09.059","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2013.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}